James B. Tananbaum, Director, 10% Owner at Kinnate Biopharma Inc. (KNTE), bought 1,000,000 shares at $20.00 ($20.0M) on 2020-12-03, disclosed to the SEC on 2020-12-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 125,000 | $2.5M | 12.5% |
| 2 | $20.00 | 375,000 | $7.5M | 37.5% |
| 3 | $20.00 | 500,000 | $10.0M | 50.0% |
| Total | $20.00 avg | 1,000,000 | $20.0M | 100% |
| Filing → |
| ALMS | BUY | 2025-11-25 | $1.1M | — | Filing → |
| ALMS | BUY | 2025-11-19 | $3.8M | — | Filing → |
| ALMS | BUY | 2025-05-06 | $202K | — | Filing → |